FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1497274320> ?p ?o ?g. }

• W1497274320 endingPage "2356" @default.
• W1497274320 startingPage "2347" @default.
• W1497274320 abstract "The reconstruction of large osseous defects due to periodontitis is a challenge in regenerative therapy. Sclerostin, secreted by osteocytes, is a key physiological inhibitor of osteogenesis. Pharmacologic inhibition of sclerostin using sclerostin-neutralizing monoclonal antibody (Scl-Ab) thus increases bone formation, bone mass and bone strength in models of osteopenia and fracture repair. This study assessed the therapeutic potential of Scl-Ab to stimulate alveolar bone regeneration following experimental periodontitis (EP). Ligature-induced EP was induced in rats to generate localized alveolar bone defects. Following 4 weeks of disease induction, Scl-Ab (+EP) or vehicle (+/− EP) were systemically delivered, twice weekly for up to 6 wks to determine the ability of Scl-Ab to regenerate bone around tooth-supporting osseous defects. 3 and 6 wks after the initiation of Scl-Ab or vehicle treatment, femur and maxillary jawbones were harvested for histology, histomorphometry, and micro-computed tomography (micro-CT) of linear alveolar bone loss (ABL) and volumetric measures of bone support, including bone volume fraction (BVF) and tissue mineral density (TMD). Serum was analyzed to examine bone turnover markers during disease and regenerative therapy. Vehicle + EP animals exhibited maxillary bone loss (BVF, TMD and ABL) at ligature removal and thereafter. 6 weeks of Scl-Ab significantly improved maxillary bone healing, as measured by BVF, TMD and ABL, when compared to vehicle + EP. After 6 weeks of treatment, BVF and TMD values in the Scl-Ab + EP group were similar to those of healthy controls. Serum analysis demonstrated higher levels of bone formation markers osteocalcin and PINP in Scl-Ab treatment groups. Scl-Ab restored alveolar bone mass following experimental periodontitis. These findings warrant further exploration of Scl-Ab therapy in this and other oral bone defect disease scenarios. © 2013 American Society for Bone and Mineral Research." @default.
• W1497274320 created "2016-06-24" @default.
• W1497274320 creator A5017353282 @default.
• W1497274320 creator A5029681004 @default.
• W1497274320 creator A5030867816 @default.
• W1497274320 creator A5044774272 @default.
• W1497274320 creator A5046679612 @default.
• W1497274320 creator A5051404631 @default.
• W1497274320 creator A5067718927 @default.
• W1497274320 creator A5073780815 @default.
• W1497274320 creator A5085393006 @default.
• W1497274320 date "2013-10-18" @default.
• W1497274320 modified "2023-10-16" @default.
• W1497274320 title "Sclerostin antibody stimulates bone regeneration after experimental periodontitis" @default.
• W1497274320 cites W132805107 @default.
• W1497274320 cites W1965029377 @default.
• W1497274320 cites W1967056245 @default.
• W1497274320 cites W1969807770 @default.
• W1497274320 cites W1983220846 @default.
• W1497274320 cites W2002725330 @default.
• W1497274320 cites W2003860200 @default.
• W1497274320 cites W2006531162 @default.
• W1497274320 cites W2021829493 @default.
• W1497274320 cites W2029361003 @default.
• W1497274320 cites W2030181973 @default.
• W1497274320 cites W2032956576 @default.
• W1497274320 cites W2037750372 @default.
• W1497274320 cites W2040400629 @default.
• W1497274320 cites W2043471018 @default.
• W1497274320 cites W2048961393 @default.
• W1497274320 cites W2054603232 @default.
• W1497274320 cites W2061031929 @default.
• W1497274320 cites W2065519748 @default.
• W1497274320 cites W2068916684 @default.
• W1497274320 cites W2078219318 @default.
• W1497274320 cites W2078883007 @default.
• W1497274320 cites W2087560312 @default.
• W1497274320 cites W2117582159 @default.
• W1497274320 cites W2118492754 @default.
• W1497274320 cites W2119934014 @default.
• W1497274320 cites W2128777779 @default.
• W1497274320 cites W2130807386 @default.
• W1497274320 cites W2134692337 @default.
• W1497274320 cites W2137818638 @default.
• W1497274320 cites W2138749227 @default.
• W1497274320 cites W2148175844 @default.
• W1497274320 cites W2172637282 @default.
• W1497274320 cites W4210956735 @default.
• W1497274320 doi "https://doi.org/10.1002/jbmr.1984" @default.
• W1497274320 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23712325" @default.
• W1497274320 hasPublicationYear "2013" @default.
• W1497274320 type Work @default.
• W1497274320 sameAs 1497274320 @default.
• W1497274320 citedByCount "88" @default.
• W1497274320 countsByYear W14972743202013 @default.
• W1497274320 countsByYear W14972743202014 @default.
• W1497274320 countsByYear W14972743202015 @default.
• W1497274320 countsByYear W14972743202016 @default.
• W1497274320 countsByYear W14972743202017 @default.
• W1497274320 countsByYear W14972743202018 @default.
• W1497274320 countsByYear W14972743202019 @default.
• W1497274320 countsByYear W14972743202020 @default.
• W1497274320 countsByYear W14972743202021 @default.
• W1497274320 countsByYear W14972743202022 @default.
• W1497274320 countsByYear W14972743202023 @default.
• W1497274320 crossrefType "journal-article" @default.
• W1497274320 hasAuthorship W1497274320A5017353282 @default.
• W1497274320 hasAuthorship W1497274320A5029681004 @default.
• W1497274320 hasAuthorship W1497274320A5030867816 @default.
• W1497274320 hasAuthorship W1497274320A5044774272 @default.
• W1497274320 hasAuthorship W1497274320A5046679612 @default.
• W1497274320 hasAuthorship W1497274320A5051404631 @default.
• W1497274320 hasAuthorship W1497274320A5067718927 @default.
• W1497274320 hasAuthorship W1497274320A5073780815 @default.
• W1497274320 hasAuthorship W1497274320A5085393006 @default.
• W1497274320 hasBestOaLocation W14972743201 @default.
• W1497274320 hasConcept C104317684 @default.
• W1497274320 hasConcept C105702510 @default.
• W1497274320 hasConcept C126322002 @default.
• W1497274320 hasConcept C131075544 @default.
• W1497274320 hasConcept C134018914 @default.
• W1497274320 hasConcept C137620995 @default.
• W1497274320 hasConcept C142724271 @default.
• W1497274320 hasConcept C151279780 @default.
• W1497274320 hasConcept C160160445 @default.
• W1497274320 hasConcept C170033053 @default.
• W1497274320 hasConcept C181199279 @default.
• W1497274320 hasConcept C185592680 @default.
• W1497274320 hasConcept C199343813 @default.
• W1497274320 hasConcept C2776541429 @default.
• W1497274320 hasConcept C2776886416 @default.
• W1497274320 hasConcept C2777083390 @default.
• W1497274320 hasConcept C2779277721 @default.
• W1497274320 hasConcept C2780385504 @default.
• W1497274320 hasConcept C55493867 @default.
• W1497274320 hasConcept C71924100 @default.
• W1497274320 hasConcept C8337478 @default.
• W1497274320 hasConceptScore W1497274320C104317684 @default.

• next